SARS-CoV-IN-2

HY-135856

SARS-CoV-IN-2

SARS-CoV-IN-2 is an effective inhibitor of SARS-CoV replication. SARS-CoV-IN-2 shows anti-Coronavirus activity with an EC50 of 1.9 μM in Vero cells. SARS-CoV-IN-2 inhibits the 3D7 and W2 strains of P. falciparum with IC50s of 21.5 and 30 nM; and IC90s of 51.0 and 99.9 nM; respectively. SARS-CoV-IN-2 reduces HIV-1-induced cytopathic effect with an EC50 of 2.9 μM in MT-4 cells. Antimalarial and Antiviral Activities[1].

3701.42 €

MBS5767570-10mg

SARS-CoV-IN-2

1689.5 €

MBS5767570-50mg

SARS-CoV-IN-2

4226.75 €

HY-149955

SARS-CoV-2-IN-38

SARS-CoV-2-IN-38 (compound 24) is a SARS-CoV-2 inhibitor with good oral bioavailability in mice (F%=39.75%)[1].

Ask for quotation

HY-150783

SARS-CoV-2-IN-24

SARS-CoV-2-IN-24 (compound 7) is a potent papain-like protease (PLpro) inhibitor. SARS-CoV-2-IN-24 induces conformational changes in SARS-COV-2 papain-like protease, inhibiting SARS-CoV-2 replication. SARS-CoV-2-IN-24 can be used for SARS-CoV-2 research[1].

Ask for quotation

HY-150789

SARS-CoV-2-IN-23

SARS-CoV-2-IN-23 (compound GRL-0617) is a SARS-COV-2 papain-like protease (PLpro) inhibitor with an IC50 value of 2.3 μM[1].

Ask for quotation